pindolol has been researched along with xamoterol in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Mehlsen, J; Trap-Jensen, J | 2 |
| Böhm, M; Erdmann, E; Mittmann, C; Schwinger, RH | 1 |
| Cruickshank, JM; Graham, BR; Hayes, Y; Jones, A; Lewis, AD; Lui, JB; Prichard, BN; Renondin, JC; Tomlinson, B | 1 |
| Barnett, DB; Haworth, D; Kowalski, MT; Lu, X; Thomson, DS | 1 |
| Hadfield, SE; Slee, SJ; Snow, HM | 1 |
| Charlier, AA; Debaisieux, JC; Pouleur, H; Rousseau, MF; Van Eyll, C | 1 |
| Malta, E; Mian, MA; Raper, C | 1 |
| Hasebe, N; Honda, H; Kawamura, Y; Kimura, T; Obara, A; Onodera, S; Yahara, O; Yamashita, H | 1 |
| Cavero, I; Hicks, PE; Langer, SZ; Lefevre-Borg, F; Manoury, P | 1 |
| Hattori, Y; Kanno, M; Nakao, Y; Sakuma, I | 1 |
| Beer, M; Hacker, S; Poat, J; Stahl, SM | 1 |
| Mehlsen, J; Stadeager, C; Trap-Jensen, J | 1 |
2 trial(s) available for pindolol and xamoterol
| Article | Year |
|---|---|
Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Creatine Kinase; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Muscle Contraction; Muscles; Pindolol; Propanolamines; Xamoterol | 1990 |
Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
Topics: Adrenergic beta-Agonists; Aged; Clinical Trials as Topic; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Pindolol; Propanolamines; Xamoterol | 1986 |
16 other study(ies) available for pindolol and xamoterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Haemodynamics in postural hypotension--effects of the beta-adrenoceptor partial agonist xamoterol, and pindolol.
Topics: Adrenergic beta-Agonists; Blood Pressure; Hemodynamics; Humans; Hypotension, Orthostatic; Pindolol; Propanolamines; Stroke Volume; Vascular Resistance; Xamoterol | 1990 |
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Heart Atria; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Pindolol; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Xamoterol | 1990 |
Comparison of the effects of xamoterol and isoprenaline on rat cardiac beta-adrenoceptors: studies of function and regulation.
Topics: Animals; Down-Regulation; Female; Heart; Heart Rate; In Vitro Techniques; Iodine Radioisotopes; Isoproterenol; Male; Pindolol; Propanolamines; Rats; Receptors, Adrenergic, beta; Xamoterol | 1990 |
The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog.
Topics: Adrenergic beta-Agonists; Anesthesia; Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Hindlimb; Isoproterenol; Pindolol; Prenalterol; Propanolamines; Regional Blood Flow; Reserpine; Xamoterol | 1989 |
Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function.
Topics: Adrenergic beta-Agonists; Blood Pressure; Coronary Disease; Diastole; Female; Heart; Heart Rate; Humans; Male; Pindolol; Propanolamines; Xamoterol | 1989 |
The in vitro pharmacology of xamoterol (ICI 118,587).
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cats; Female; Fenoterol; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Male; Muscle, Smooth; Norepinephrine; Pindolol; Propanolamines; Rats; Refractory Period, Electrophysiological; Species Specificity; Uterine Contraction; Xamoterol | 1985 |
Treatment of idiopathic orthostatic hypotension with xamoterol.
Topics: Adrenergic beta-Agonists; Humans; Hypotension, Orthostatic; Male; Middle Aged; Pindolol; Propanolamines; Xamoterol | 1987 |
Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Pindolol; Propanolamines; Propranolol; Rats; Receptors, Adrenergic, beta; Trachea; Xamoterol | 1987 |
Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Topics: Adenosine; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbachol; Cyclic AMP; Dose-Response Relationship, Drug; Female; Guanylyl Imidodiphosphate; Guinea Pigs; Heart; Heart Rate; Iodocyanopindolol; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Xamoterol | 1987 |
Independent regulation of beta 1- and beta 2-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Cerebral Cortex; Clenbuterol; Desipramine; In Vitro Techniques; Iodine Radioisotopes; Male; Pindolol; Prenalterol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Xamoterol | 1987 |
Differential effects of beta-adrenoceptor partial agonists in patients with postural hypotension.
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Pindolol; Supine Position; Xamoterol | 1993 |